{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:50:04Z","timestamp":1792043404535,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T00:00:00Z","timestamp":1694908800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020552","name":"Ministry of Higher Education, Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020552","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011045","name":"Minist\u00e8re de l'Enseignement sup\u00e9rieur, de la Recherche et de l'Innovation","doi-asserted-by":"publisher","award":["25284\u20132020050308076476 v2"],"award-info":[{"award-number":["25284\u20132020050308076476 v2"]}],"id":[{"id":"10.13039\/501100011045","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015723","name":"Universit\u00e9 Clermont-Auvergne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020098","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["821528"],"award-info":[{"award-number":["821528"]}],"id":[{"id":"10.13039\/100020098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.biopha.2023.115535","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T16:53:38Z","timestamp":1695228818000},"page":"115535","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel - NeuroDeRisk project"],"prefix":"10.1016","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6126-6588","authenticated-orcid":false,"given":"David","family":"Balayssac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Busserolles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Broto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristelle","family":"Dalbos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Prival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6216-8509","authenticated-orcid":false,"given":"Sylvain","family":"Lamoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lia","family":"Herbet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Hilairet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1557-4416","authenticated-orcid":false,"given":"Irena","family":"Loryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren E.","family":"Glaab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Micheli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Ghelardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8374-4432","authenticated-orcid":false,"given":"Lorenzo","family":"Di Cesare Mannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Perrault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Slaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.115535_bib1","first-page":"2351","article-title":"Fluid biomarkers for monitoring structural changes in polyneuropathies: their use in clinical practice and trials","volume":"18","author":"Wieske","year":"2021","journal-title":"Neurother. J. Am. Soc. Exp. Neurother."},{"key":"10.1016\/j.biopha.2023.115535_bib2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2023.115535_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.expneurol.2018.06.005","article-title":"Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy","volume":"307","author":"Meregalli","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2023.115535_bib4","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1007\/s00204-020-02755-w","article-title":"Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity","volume":"94","author":"Meregalli","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.biopha.2023.115535_bib5","article-title":"Serum neurofilament light chain levels as a biomarker of neuroaxonal injury and severity of oxaliplatin-induced peripheral neuropathy","volume":"10","author":"Kim","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115535_bib6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/jns.12493","article-title":"Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel-induced peripheral neurotoxicity in breast cancer patients","volume":"27","author":"Karteri","year":"2022","journal-title":"J. Peripher. Nerv. Syst. Jpns."},{"key":"10.1016\/j.biopha.2023.115535_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrneurol.2016.88","article-title":"Vascular endothelial growth factor: a neurovascular target in neurological diseases","volume":"12","author":"Lange","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2023.115535_bib8","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-021-02127-x","article-title":"VEGF-A\/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody","volume":"40","author":"Micheli","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2023.115535_bib9","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ccell.2015.04.017","article-title":"A functional role for VEGFR1 expressed in peripheral sensory neurons in cancer pain","volume":"27","author":"Selvaraj","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2023.115535_bib10","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neuropharm.2017.12.020","article-title":"Adipose-derived stem cells decrease pain in a rat model of oxaliplatin-induced neuropathy: Role of VEGF-A modulation","volume":"131","author":"Di Cesare Mannelli","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2023.115535_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221787","article-title":"A systematic summary and comparison of animal models for chemotherapy induced (peripheral) neuropathy (CIPN)","volume":"14","author":"Gadgil","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.biopha.2023.115535_bib12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fphar.2017.00086","article-title":"Long-term effects, pathophysiological mechanisms, and risk factors of chemotherapy-induced peripheral neuropathies: a comprehensive literature review","volume":"8","author":"Kerckhove","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115535_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.biopha.2023.115535_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/ijms23010098","article-title":"The Class I HDAC inhibitor, MS-275, prevents oxaliplatin-induced chronic neuropathy and potentiates its antiproliferative activity in mice","volume":"23","author":"Lamoine","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115535_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuropharm.2018.07.026","article-title":"Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin","volume":"140","author":"Poupon","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2023.115535_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/j.1532-2149.2012.00172.x","article-title":"Paclitaxel-induced neuropathic pain is age dependent and devolves on glial response","volume":"17","author":"Ruiz-Medina","year":"2013","journal-title":"Eur. J. Pain. Lond. Engl."},{"key":"10.1016\/j.biopha.2023.115535_bib17","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1016\/j.lfs.2004.01.002","article-title":"Paclitaxel-induced neuropathic hypersensitivity in mice: responses in 10 inbred mouse strains","volume":"74","author":"Smith","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2023.115535_bib18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/10915818909009095","article-title":"Screening approaches to neurotoxicity: a functional observational battery","volume":"8","author":"Moser","year":"1989","journal-title":"J. Am. Coll. Toxicol."},{"key":"10.1016\/j.biopha.2023.115535_bib19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3109\/10915819109078660","article-title":"Strategy for and experience with neurotoxicity testing of new pharmaceuticals","volume":"10","author":"Haggerty","year":"1991","journal-title":"J. Am. Coll. Toxicol."},{"key":"10.1016\/j.biopha.2023.115535_bib20","first-page":"362","article-title":"Influence of certain parameters on the performance of mice on the rotarod","volume":"169","author":"Watzman","year":"1967","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.biopha.2023.115535_bib21","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/cbdd.13507","article-title":"Searching for analgesic drug candidates alleviating oxaliplatin-induced cold hypersensitivity in mice","volume":"93","author":"Sa\u0142at","year":"2019","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.biopha.2023.115535_bib22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/B978-0-444-52902-2.00042-4","article-title":"Drug-induced neuropathies","volume":"115","author":"Manji","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.biopha.2023.115535_bib23","doi-asserted-by":"crossref","DOI":"10.1007\/s40800-017-0045-0","article-title":"Physicians\u2019 experiences as patients with statin side effects: a case series","volume":"4","author":"Koslik","year":"2017","journal-title":"Drug Saf. - Case Rep."},{"key":"10.1016\/j.biopha.2023.115535_bib24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s12035-019-01698-3","article-title":"Neurofilament light chain as a biomarker, and correlation with magnetic resonance imaging in diagnosis of CNS-related disorders","volume":"57","author":"Alirezaei","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2023.115535_bib25","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/acn3.51234","article-title":"Blood neurofilament light: a critical review of its application to neurologic disease","volume":"7","author":"Barro","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.biopha.2023.115535_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23620-z","article-title":"A multicentre validation study of the diagnostic value of plasma neurofilament light","volume":"12","author":"Ashton","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.115535_bib27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s40520-021-02054-z","article-title":"Neurofilament light chain concentration in an aging population","volume":"34","author":"Ladang","year":"2022","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.biopha.2023.115535_bib28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/acn3.50972","article-title":"Confounding effect of blood volume and body mass index on blood neurofilament light chain levels","volume":"7","author":"Manouchehrinia","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.biopha.2023.115535_bib29","doi-asserted-by":"crossref","DOI":"10.1097\/j.pain.0000000000002963","article-title":"Broad-spectrum neuroprotection exerted by DDD-028 in a mouse model of chemotherapy-induced neuropathy","author":"Lucarini","year":"2023","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2023.115535_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.154395","article-title":"Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy","volume":"7","author":"Huehnchen","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2023.115535_bib31","article-title":"Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers","volume":"12","author":"Kim","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2023.115535_bib32","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/j.pain.0000000000002840","article-title":"Neurofilament light chain as a biomarker of axonal damage in sensory neurons and paclitaxel-induced peripheral neuropathy in patients with ovarian cancer","volume":"164","author":"Mortensen","year":"2022","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2023.115535_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-18716-5","article-title":"Neurofilament light as a predictive biomarker of unresolved chemotherapy-induced peripheral neuropathy in subjects receiving paclitaxel and carboplatin","volume":"12","author":"Burgess","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115535_bib34","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00415-022-11377-4","article-title":"Serum neurofilament levels correlate with electrodiagnostic evidence of axonal loss in paclitaxel-induced peripheral neurotoxicity","volume":"270","author":"Velasco","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.biopha.2023.115535_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9082400","article-title":"Long-term prevalence of sensory chemotherapy-induced peripheral neuropathy for 5 years after adjuvant FOLFOX chemotherapy to treat colorectal cancer: a multicenter cross-sectional study","volume":"9","author":"Selvy","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2023.115535_bib36","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.biopha.2023.115535_bib37","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.36695","article-title":"Hemoglobin, body mass index, and age as risk factors for paclitaxel- and oxaliplatin-induced peripheral neuropathy","volume":"4","author":"Mizrahi","year":"2021","journal-title":"JAMA Netw. Open."},{"key":"10.1016\/j.biopha.2023.115535_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fpain.2021.683168","article-title":"Impact of dose, sex, and strain on oxaliplatin-induced peripheral neuropathy in mice","volume":"2","author":"Warncke","year":"2021","journal-title":"Front. Pain. Res."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:44:14Z","timestamp":1776462254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223013331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":38,"alternative-id":["S0753332223013331"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115535","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel - NeuroDeRisk project","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115535","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115535"}}